D
Knight Therapeutics Inc. KHTRF
$4.72 $0.000.00% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 130.90K 7.83M 2.94M -22.61M -15.52M
Total Depreciation and Amortization 35.98M 36.83M 38.09M 36.55M 36.94M
Total Amortization of Deferred Charges 662.90K 662.90K 662.90K 648.30K 648.30K
Total Other Non-Cash Items 575.50K -5.30M -855.90K 25.78M 23.26M
Change in Net Operating Assets -15.43M -33.53M -14.00M -1.39M 1.28M
Cash from Operations 21.92M 6.49M 26.84M 38.98M 46.61M
Capital Expenditure -1.38M -1.44M -1.85M -1.77M -1.67M
Sale of Property, Plant, and Equipment 92.30K 94.50K 116.60K 1.46M 1.46M
Cash Acquisitions -77.25M -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 49.06M 53.66M 13.60M -2.11M 15.99M
Cash from Investing -29.48M 52.32M 11.86M -2.43M 15.78M
Total Debt Issued 113.38M 4.74M 3.47M 2.93M 4.00M
Total Debt Repaid -69.59M -21.62M -21.52M -25.65M -25.97M
Issuance of Common Stock 1.07M 1.04M 1.00M 957.00K 597.00K
Repurchase of Common Stock -10.98M -12.21M -8.87M -22.80M -30.16M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -7.05M -7.29M -7.63M -9.32M -9.67M
Cash from Financing 19.60M -25.43M -24.30M -39.57M -45.07M
Foreign Exchange rate Adjustments -500.80K 1.49M 1.17M 341.70K 17.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 11.54M 34.88M 15.57M -2.68M 17.33M